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P2X receptorThe growth of a pluripotent embryonic stem (ES) cell population is dependent on cell survival, proliferation
and self-renewal. The nucleotide ATP represents an important extracellular signalling molecule that regulates
the survival of differentiated cells, however, its role is largely undeﬁned in embryonic stem cells. Here we re-
port a role for ATP-gated P2X7 receptors in ES cell survival. The functional expression of P2X7 receptors in
undifferentiated mouse ES cells is demonstrated using a selective P2X7 antagonist and small interfering
RNA knockdown of these receptors. Our data illustrate a key role for the P2X7 receptor as an essential pro-
survival signal required for optimal ES cell colony growth in the presence of leukemia inhibitor factor (LIF).
However, chronic exposure to exogenous ATP leads to rapid P2X7-dependent cell death via necrosis. Togeth-
er, these data demonstrate a novel role for P2X7 receptors in regulation of ES cell behaviour where they can
mediate either a pro-survival or pro-death signal depending on the mode of activation.
© 2011 Elsevier Inc. Open access under CC BY license.1. Introduction
Mouse embryonic stem (ES) cells are derived from the inner cell
mass of day 3.5 pre-implantation blastocysts [1,2]. The unique and
deﬁning properties of ES cells are that they can self-renew, proliferate
whilst remaining in an undifferentiated state and are pluripotent,
maintaining the capacity to differentiate into all cell types of the
adult organism [3]. ES cell behaviour is regulated by external signal-
ling molecules including LIF, via STAT3 and Myc activation [4–6];
bone morphogenetic proteins (BMP2 and 4) via the induction of Id
proteins [7] and Wnts [8]. Extracellular adenosine 5′ triphosphate
(ATP) has been extensively studied as an autocrine- and paracrine-
signalling molecule in differentiated cells of the adult organism [9].
Extracellular ATP has been shown to act as both a pro-survival signal
in a range of cancers and a pro-death signal in the innate immune sys-
tem [10]. However, relatively little is known about the potential con-
tribution of ATP signalling during embryonic development or
whether it inﬂuences the behaviour of ES cells. Extracellular ATP
binds to membrane purinergic receptors that include ionotropic P2X, humanembryonic kidney293.
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 license.receptors and metabotropic P2Y receptors. An early study reported
the expression of P2X3, P2X4, P2Y1 and P2Y2 receptor mRNA in
mouse ES cells (E14TG2a) where ATP is reported to have a prolifera-
tive action [11]. However, this study did not investigate the expres-
sion or contribution of P2X7 receptors [11]. Whilst other studies
report mRNA encoding P2X2, P2X5, P2X7, P2Y1, P2Y2 and P2Y6 can
be detected in mouse ES cells [12,13], the functional expression and
potential role of P2X7 receptor-coupled ion channels in undifferen-
tiated mouse ES cells have not been investigated.
P2X7 is a uniquemember of the P2X family since: i) relatively high
concentrations of ATP are required to fully activate the receptor, and
ii) the receptor has an extended C-terminal, intracellular domain,
which is involved in coupling receptor activation to downstream sig-
nalling events such as membrane permeabilisation to large molecular
dyes [14]. These signalling events are often associated with cell death,
and sustained stimulation with millimolar ATP leads to apoptotic or
necrotic cell death [10]. Indeed, in the immune system ATP is de-
scribed as a ‘danger associated molecular pattern (DAMP)’ where it
signals as a pro-apoptotic/necrotic molecule. However, several stud-
ies have reported a pro-survival role of P2X7 receptors [15–19]. It is
proposed that P2X7 receptor can detect low basal levels of ATP, likely
to be due to autocrine or paracrine ATP release, that promotes cell
survival and growth. Indeed, increased P2X7 expression is reported
as a cancer cell biomarker where the receptor couples to a change
in growth rate and cell survival [19]. Mitochondria calcium (Ca2+),
endoplasmic reticulum Ca2+ and the transcription factor NFATc
have all been implicated in P2X7-driven cell survival [16,17]. Overall,
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in the adult organism.
This study has speciﬁcally focused on the functional expression
of the P2X7 receptor which is classically considered to be a receptor
expressed by immune and epithelial cells of the adult organism.
Speciﬁcally, we have investigated the expression of speciﬁc P2X7
receptor isoforms by RT-PCR and the functional expression of P2X7
gated ion channels. Using pharmacological inhibition and knock-down
approaches to inhibit P2X7 receptor activation, we reveal the role of
P2X7 in mouse ES cell survival. The outcomes of this study have impor-
tant implications in our understanding of ion channel expression and
extracellular signalling molecules in mouse ES cell function.
2. Materials and methods
2.1. Reagents
Reagents were obtained from Sigma-Aldrich Company Ltd.,
Dorset, UK unless stated. Tissue culture reagents were obtained from
Invitrogen, Paisley, UK, unless otherwise stated. A438079 was
purchased from Tocris, Bristol, UK. Penicillin/streptomycin was
from Invitrogen and endothelial cell growth medium (ECGM)
from PromoCell (Heidelberg, Germany).
2.2. ES cell culture
The mouse ES cell line E14tg2a was maintained as previously de-
scribed [20,21] by culture in knock-out Dulbecco'sModiﬁed EagleMedi-
um (KO-DMEM) (Invitrogen) supplemented with 15% (v/v) knock-out
serum replacement, 2 mM glutamine, 0.1 mM 2-mercaptoethanol, 1%
(v/v) non-essential amino acids and 1000 U/ml ESGRO (LIF) (Chemicon
Temecula, CA) (complete media). Cells were washed in phosphate buff-
ered saline and detached with 0.05% trypsin/EDTA before being plated
as required.
2.3. HUVEC cell culture
The use of human umbilical cords and isolated cells in this research
was granted ethical consent (Bath Local Research Committee reference
BA635). Endothelial cells were isolated from umbilical cords and
cultured using a modiﬁed protocol previously described [22]. Brieﬂy,
umbilical veins were cannulated, perfused with HBSS to remove cord
blood and then incubated with collagenase (1 mgml−1) for 45 min at
ambient room temperature (20–25 °C) to disrupt the endothelial lining.
Following incubation the collagenase solution was washed through
with HBSS and the cell suspension was collected. Cells were collected
by centrifugation at 240 ×g for 4 min and re-suspended in ECGM sup-
plemented with 100 U ml−1 penicillin and 100 μg ml−1 streptomycin.
HUVECs were grown on tissue culture treated plastics and medium
was changed three times a week. Upon reaching conﬂuence cells were
dissociated using a non-enzymatic cell dissociation solution (C5789,Table 1
Oligonucleotide primers.





ENSMUST00000100737 P2X7 A F GC
R AG
ENSMUST00000121489 P2X7 C P2X7B F GT
R TA
ENSMUST00000031425 P2X7 B F GT
R TC
ENSMUST00000086247 P2X7 D Pan P2X7 F GC
R GG
ENSMUST00000167557 P2X7 K F CT
PanP2X7 R AASigma, UK). In all experiments HUVECs were used at passage 2 and
measurements performed in a physiological saline containing (in
mM) 130 NaCl, 5 KCl, 1.5 CaCl2, 1 MgCl2, 5 NaHCO3, 1.5 KH2PO4, 10 D-
glucose and 25 HEPES (pH 7.3 with NaOH).
2.4. RT-PCR
RNA was extracted by lysis in 200 μl TRIzol reagent (Invitrogen)
according to manufacturer protocols, RNA was isolated, DNase trea-
ted and reverse transcribed as previously described [23]. RT-PCR
was carried out using HotStarTaq Plus DNA polymerase (Qiagen, Hil-
den, Germany) according to the manufacturer recommendations
using the primers listed in Table 1.
2.5. siRNA transfections
ON-TARGETplus SmartPOOL siRNA targeting murine P2X7 mRNA
and a non-targeting (NT) control were purchased from Dharmacon
(Lafayette, CO, USA) and transfected at a range of concentrations as
previously described [13]. Lipofectamine 2000 (Invitrogen) and siRNA
were incubated separately with 50 μl KO-DMEM, without supplements
for 5 min, thesewere gentlymixed and incubated for a further 20 min at
room temperature. 1×105 ES cells were then added to the siRNA/Lipo-
fectamine mix and plated onto a gelatin-coated 12 well tray (NUNC) in
complete media. 24 h later media was replaced and 48 h after initial
transfection cells were washed in PBS and transfected in a similar fash-
ion whilst still attached. After a further 24 h transfected cells were
washed, trypsinised and plated for ethidium (Et+) inﬂux assays as
well as RNA extraction to evaluate mRNA reduction. For each experi-
ment, pan-P2X7 primers were used to detect the expression of P2X7.
2.6. Ethidium inﬂux
Measurements of Et+ inﬂux, as a measure of pore formation, are
as previously described [24–26]. Prior to Et+ inﬂux measurement,
cells were plated for 4 h in complete medium in a gelatin-coated 96
well black plate at a seeding density of 1.5×106 ml−1. Complete
medium was removed and cells were incubated at 37 °C in PBS
containing 25 μM EtBr. Fluorescent measurements were performed
using a multi-detection plate reader (Fluostar Optima, BMG Labtech,
UK) with excitation wavelength of 540 nm and emission wavelength
of 590 nm. For the ATP dose response curve, the rates of dye inﬂux
(dye uptake slopes) were normalised to 1 mM ATP responses.
2.7. Whole cell patch clamp recordings
For whole cell recordings, mouse ES cells were plated onto
gelatin-coated glass cover slips for 4 h and used within 4 h. Whole cell
recordings were performed as previously described [27] using a HEKA
EPC10 patch clamp ampliﬁer and data collected using PatchMaster
software (HEKA). Current recordings were performed at ambient roomquence 5′-3′ Annealing temp (°C) Product size Isoforms
TGGAACGATGTCTTGC 56 292 bp A, B, C, D
GAATGAGTTCCCCTGC
CAAGAAGTTCCAAGACC 59 292 bp A, K
GGTGTCTCGGGACAGC
TTTCGGCACTGGAGGA 51 317 bp C
GGTTGGAACTTCTTGG
TTTCGGCACTGGAGGA 54 309 bp B
AGGTCGCCATACATACAT
TGGAACGATGTCTTGC 55 360 bp D
TTGGAAAGATCCTCAG
GCCCGTGAGCCACTTAT 56 303 bp K
GAATGAGTTCCCCTGC
772 B.A.N. Thompson et al. / Cellular Signalling 24 (2012) 770–778temperature. Membrane potential was held at −60 mV. Agonists and
antagonists were applied using a rapid solution changer (Biologic,
France). Borosilicate glass microelectrodes, 3–5 MΩ are ﬁlled with solu-
tions containing (in mM) 145 KCl, 10 HEPES and 1 EGTA (pH 7.3 with
KOH). Cell stimulations were carried out using an external physiological
salt solution containing (inmM) 147 NaCl, 2 KCl, 10 HEPES, 12 glucose, 2
CaCl2 and 1 MgCl2 (pH 7.3 with NaOH). Peak currents were deﬁned as
the maximal amplitude of response during the agonist application in
the presence or absence of antagonists; responses were plotted as cur-
rent density (pA/pF).
2.8. Alkaline phosphatase self-renewal assays
E14tg2a mouse ES cells were plated at a cell density of 1500 cells/
well in a gelatin-coated six-well dish (Nunc) containing KO-DMEM
medium, serum replacement, 10% (v/v) foetal bovine serum (Hyclone,
ThermoFisher) and 1000 U.ml−1 LIF. Alternatively GMEM+10% (v/v)
foetal bovine serum (Hyclone, ThermoFisher)+1000 U.ml−1 LIF were
used. A438079 was added as indicated. After culture for 5 days, ES
cells were stained for alkaline phosphatase activity as previously de-
scribed (20) by incubating for 25 min in 0.1 M Tris solution (pH 9.2)
containing 0.2 mg.ml−1 Napthol AS-MX phosphate and 0.5 mg.ml−1
Fast Violet B salt. Colony numbers and percentage alkaline phosphatase
positive cells were counted.
2.9. Proliferation assay
E14tg2amouse ES cells were cultured on gelatin-coated Nunc tissue
culture plastic in KO-DMEM medium with knock-out serum replace-
ment with the addition of 1000 U.ml−1 LIF. For proliferation assays,
3000 cells/well were plated into gelatin-coated 96 well plates in
GMEM culture medium with 10% Hyclone FBS and 1000 U.ml−1 LIF in
the presence of inhibitors as indicated. Proliferation was evaluated
using a CellTitre 96 AQueous (MTS) assays (Promega) where
absorbance (490 nm) was measured using a VersaMax plate reader
(Molecular Devices).
2.10. Online ATP assay
A sensitive bioluminescent-based assay capable of detecting ATP
in the range of 2×10−12 to 8×10−5 M was used to analyse ATP
hydrolysis by HUVECs and ES cells. The ATP assay mix (containing
luciferase, luciferin, MgSO4, dithiothreitol, EDTA, bovine serum albumin,
and tricine buffer salts) used in this procedure was prepared by adding
5 ml sterile distilled water to the lyophilised powder supplied and
100 μl aliquots of this concentrate were stored at −20 °C. On-line ATP
assayswere performed using a FLUOstar OPTIMAmulti-well plate reader
(BMG Labtech, Offenburg, Germany) with temperature control set at
30 °C to prevent luciferase inactivation that occurs above this tempera-
ture [28]. HUVECs were seeded 45,000 cells per well in white, 96-well,
tissue culture-treated plates the day before experimentation. E14tg2a
mouse ES cells were cultured on gelatin coated Nunc tissue culture plas-
tic (150,000 cells per well) in KO-DMEMmediumwith knockout serum
replacement with the addition of 1000 U.ml−1 LIF. For ATP hydrolysis
studies cells were washed once in 100 μl physiological saline to remove
culture medium. Measurements of ATP hydrolysis were performed
where the luciferin/luciferase mix was added directly onto the cells
(diluted 25 times in the ﬁnal well volume) and luminescence detected
as photons by a photomultiplier tube in the plate reader. The rate of
ATP degradation is calculated as the change in detected ATP levels
per minute in the presence of exogenous ATP.
2.11. Cell viability
E14tg2a mouse ES cells were plated for 4 h in complete medium in
a gelatin-coated 96 well clear plate at a seeding density of1.5×106 ml−1. Complete medium was removed and cells were incu-
bated at 37 °C in PBS containing the test substance. Supernatants
were removed and added to Cytotoxicity Detection Kit (Roche
Applied Science, Burgess Hill, UK) reaction mixture. Absorbance of
samples at 490 nm was measured using a multi-detection plate
reader (Fluostar Optima, BMG Labtech, UK) or a VersaMax plate
reader (Molecular Devices). Total cellular LDH was determined by
the addition of 1% Triton-X 100 to untreated cells, and the amount
of LDH released is expressed as a percentage of the total LDH release.
2.12. Nanog-GFP
Nanog-GFP cells (generated by recombineering an eGFP knock-in at
a Nanog allele) [29] were cultured on gelatin coated 6-well Nunc dishes
at 8×104 per dish for 48 h or 3×104 for 72 h in KO-DMEM+15% KO-
serum replacement and 1000 U.ml−1 LIF as described above, in the
presence or absence of 10 μMA438079. After 48 h or 72 h cells were re-
moved from the dish by trypsin treatment as described above, washed
3× in PBS+5% FBS and re-suspended in PBS+5% FBS. Flow cytometry
was carried out using a FACSCanto (Becton Dikinson, Oxford, UK) and
data was analysed using FACSDiva software. Dead cells were excluded
from analysis based on forward and side scatter parameters.
2.13. Data analysis
Data points shown in graphs represent themean±standard error of
the mean (SEM) with a minimum of three independent data points
where n values are indicated in the ﬁgures and text. Where indicated
in the ﬁgure legend, data were analysed using an unpaired two-tailed
t test using GraphPad InStat 3.1 (GraphPad Software). The agonist–
dose response curves were ﬁt using R/Rmax=100([A]nH/([A]nH+
EC50
n
H), where [A] represents agonist concentration, R is the ﬂuores-
cence response induced by [A] expressed as a function of the peakmax-
imal agonist response (Rmax), nH is the Hill coefﬁcient and EC50 the half
maximal response. The pEC50 value represents the negative logarithm
to base 10 of the EC50 value.
3. Results
3.1. Expression of functional P2X7 receptors in mouse ES cells
To date, one study has investigated the functional role of ATP acti-
vated P2 receptors in mouse ES cells [11]. The authors report a role for
P2Y and P2X in ATP-induced proliferation using broad-spectrum,
non-selective P2 receptor inhibitors (suramin and reactive blue 2).
This study did not investigate P2X7 mRNA expression though it did
detect the expression of P2X3 and P2X4 mRNA. We have investigated
the expression of mouse P2X7 splice variants and detect the expres-
sion of P2X7a-d and P2X7k by RT-PCR (Fig. 1A). We conducted
whole-cell patch clamp recordings to investigate the potential ex-
pression of native ATP-gated P2X7 receptors in mouse ES cells. The
membrane capacitance of patch-clamped ES cells ranged from 5.9 to
100 pF (21±4.5 pF, n=23). Cells were voltage-clamped at −60 mV
and brief 10 s applications of 5 mMATP elicited sustained inward cur-
rents with a mean current density of 14.6±3.7 pA/pF (n=19,
Fig. 1B). Maximal current was detected at 5 mM ATP and no currents
could be detected with the application of 100 μM ATP (Fig. 1B). A dis-
tinct property of P2X7 activation is the ability to elicit the inﬂux of
large molecular weight cations such as the ﬂuorescent dye Et+. In
mouse ES cells, extracellular ATP triggers Et+ uptake with an appar-
ent pEC50 value of 3.45±0.13 (n=5) where the maximal rate was
detected at 1 mM ATP (Fig. 1C and D). The ATP concentration re-
sponse curve decreases at ATP concentrations greater than 1 mM
ATP, this has also been observed for P2X7 responses in mouse macro-
phages [24,30].
Fig. 1. Expression of P2X7mRNA transcripts and functional assays of P2X receptor expression. (A) RT-PCR was performed for P2X7 variants using the primers described in Table 1. Am-
pliﬁcation products of the expected size were detected where E represents mouse embryonic stem cells, M represents J774.2 mouse macrophages and -T is the no template control.
(B)Whole cell patch clamp recordings fromundifferentiatedmouse ES cells at the holding potential of−60 mV. Histogram summarises themean peak currents normalised tomembrane
capacitance detected at the ATP concentrations given. (C) Membrane permeabilisation measured by the uptake of ethidium and corresponding increase in ﬂuorescent signal (544 nm
excitation; 590 nmemission). An example kinetic trace of ethidiummeasurements frommouse ES cells with a saline vehicle (○) versus the addition of 1 mMATP (●). (D) Concentration
response relationship for ATP versus the rate of ethidium inﬂux normalised to 1 mM ATP responses (n=5) as described in methods. Data are plotted as the mean±SEM.
Fig. 2. Pharmacological evidence for the expression of P2X7 receptors in mouse ES cells. Whole cell voltage clamp recordings from mouse ES cells with a holding potential
of −60 mV. Reversible inhibition of ATP-mediated current with a selective P2X7 antagonist A438079. Application of 5 mM ATP in the absence or presence of 10 μM A438079
as indicated.
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knockdown of P2X7 to investigate the contribution of P2X7 to ATP-
mediated ionic currents and Et+ inﬂux. Co-application of 10 μM
A438079 with 5 mM ATP reversibly inhibited evoked currents by
83% (n=3, Fig. 2). The action of A438079 and P2X7-targeted siRNA
was investigated on the observed ATP-mediated Et+ inﬂux. Co-
application of 10 μM A438079 with 1 mM ATP inhibited Et+ efﬂux
compared to control rates (n=3, Fig. 3A). Semi-quantitative RT-PCR
analysis of ES cells transfected with P2X7-targeting siRNAs showed
reduced expression of P2X7 mRNA that was not seen with control
non-targeting siRNAs (Fig. 3B). Et+ uptake mediated by 1 mM ATP
was reduced in ES cells transfected with P2X7 siRNA compared to
control non-targeting siRNA (n=3, Fig. 3C). Together, these data
demonstrate the expression of P2X7 receptors in mouse ES cells
that is coupled to an ionic current and mediates increased membrane
permeability to Et+.
3.2. Exogenous ATP activates P2X7 receptor mediated necrotic cell death
In differentiated cells of the immune system, P2X7 activation is
associated with rapid loss of cell viability by necrotic or apoptotic
cell death [24,30,32–34]. We have investigated cell viability, and
speciﬁcally necrotic cell death, upon exposure of mouse ES cells
to exogenous ATP. Necrosis was detected by the release of lactate
dehydrogenase (LDH) into the external medium as a function of total
cellular LDH. Stimulation with exogenous ATP elicited the release of
LDH following 45 min of agonist application (Fig. 4). Reduction of
P2X7 receptor expression by siRNA resulted in an attenuation ofFig. 3. Evidence for P2X7 receptor expression by siRNA knockdown of receptor expression.
A438079 as indicated in the ﬁgure. Buffer control (ο) or addition of 1 mM ATP (●) as indica
by transfection of mouse ES cells with P2X7 targeting siRNA (P2X7 siRNA) versus a non-targ
semi-quantitative RT-PCR using panP2X7 primers and β-actin as a positive control (primers
of P2X7 expression versus cells treated with the 20 nM control non-targeting (NT) siRNA aATP-mediated cell lysis demonstrating a role for P2X7 receptors
(Fig. 4). Next we investigated the metabolism of exogenous ATP by ES
cells compared to human umbilical vein endothelial cells (HUVECs)
which have previously been demonstrated to have high NTP dipho-
sphohydrolase CD39 activity [35]. HUVECs rapidly degraded exogenous
ATP with an initial rate of 4.03±0.26 nMmin−1 (n=4) whilst mouse
ES cells degraded ATP with an initial rate of 1.41±0.37 nMmin−1
(n=5) (Fig. 5A–C). These data demonstrate that exposure to high
ATP concentrations leads to detectable necrotic cell death, and that
mouse ES cells break down extracellular ATPmore slowly thanHUVECs.
Although the ATP concentration within the environment surrounding
the inner cell mass is unknown, this study demonstrates that mouse
ES cells slowly metabolise exogenous ATP which maybe an important
characteristic of these cells to facilitate the detection of excessive auto-
crine or paracrine ATP release.
3.3. Role of P2X7 receptors in ES cell proliferation, self-renewal and
colony formation
Next we investigated whether endogenous ATP could activate
P2X7 and whether this played an important functional role in the
cell survival, self-renewal or proliferation of mouse ES cells. Previous
studies have shown that exogenous ATP increases cell proliferation
but did not alter alkaline phosphatase activity in the absence of
serum [11]. Broad-spectrum P2 receptor inhibitors (suramin and re-
active blue 2) reduced exogenous ATP elicited proliferation but did
not alter basal proliferation in the presence of endogenous ATP [11].
In the current study, we measured basal extracellular ATP in the ES(A) An example of ATP-mediated ethidium uptake in the absence or presence of 10 μM
ted. Representative of 3 independent experiments. (B) Knockdown of P2X7 expression
eting control siRNA (NT siRNA) as indicated. P2X7 receptor expression was assessed by
Table 1). (C) Ethidium uptake is reduced in cells treated with 20 nM siRNA knockdown
s indicated in the ﬁgure. Representative of 3 independent experiments.
Fig. 4. Stimulation of mouse ES cells with exogenous ATP leads to necrosis. Release
of lactate dehydrogenase (LDH) as a function of total cellular LDH (plotted as % total
cellular LDH) for mouse ES cells transfected with 20 nM non-targeting siRNA (NT
siRNA) or P2X7-targeted siRNA (P2X7 siRNA) as indicated (n=3). Cells stimulated
with ATP for 45 min at 37 °C. * Pb0.05 by unpaired two-tailed t test.
775B.A.N. Thompson et al. / Cellular Signalling 24 (2012) 770–778cell culture using the luciferase detection system as 0.54±0.17 nM
(n=4). This is however a global measure of external ATP in the culture
and does not reﬂect localised near-cell ATP levels thatwould be predicted
to be substantially higher. To investigate the role of endogenous ATP and
P2X7 activation in ES cell proliferation we used an MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) assay. In the presence of serum, it was found that P2X7
inhibition with A438079 or incubation with an ecto-ATPase (Apyrase)Fig. 5. Comparisonof exogenousATPhydrolysis betweenmEScells andhumanumbilical vein endo
for HUVEC (A) or mES cells (B). (C) Histogram comparing the rate of ATP metabolism for HUVEC
unpaired two-tailed t test.did not reduce cell proliferation (48 h: 10 μM A438079: 114±2.9% con-
trol (n=9) and 4 Uml−1 Apyrase: 112±3% control (n=6)). These
data demonstrate that endogenous ATP does not alter ES cell proliferation
via P2X7 receptor activation.
In ES cells, self-renewal is deﬁned as proliferation accompanied by
the suppression of differentiation to generate two identical daughter
cells. To assess the role of P2X7 in self-renewal, ES cells were plated at
a clonal density in the presence of LIF (and serum) in the presence or
absence of the P2X7 antagonist, A438079. After 5 days, colonies were
ﬁxed and stained for alkaline phosphatase activity, expressed only by
undifferentiated cells and hence a suitable marker of self-renewal
[20]. Colonies that stained intensely for alkaline phosphatase and
had a compact round morphology were deﬁned as the ‘pure’ alkaline
phosphatase positive colonies. Such colonies represent highly self-
renewing ES cells. Our results demonstrate that treatment with
10 μM A438079 did not signiﬁcantly alter the level of self-renewal
compared to control cultures (n=3, Fig. 6A and B). However, in the
presence of the P2X7 antagonist A438079 (10 μM) the total colony
number was reduced by 29±17% (n=3) in GMEM medium or 35±
10.2% (n=3) in KO-DMEM compared to control untreated cells
(Fig. 6C). Finally we have investigated the expression of a pluripotent
cell speciﬁc transcription factor Nanog using mES cells expressing
Nanog-green ﬂuorescent protein (Nanog-GFP) [29]. It was found that
Nanog-GFP expression was not altered by culture in the presence of
10 μM A438079 conﬁrming that P2X7 inhibition does not alter ES cell
self-renewal (Fig. 6D). In summary, P2X7 receptors do not regulate ES
cell proliferation or self-renewal in response to endogenous ATP release
but our data indicates a novel role in ES stem cell colony survival.
4. Discussion
Few studies have investigated the expression or functional role of
P2X receptors during development, particularly in relation to P2X7thelial cells. (A–B)Measurement of extracellular ATP levels following additionof 100 nMATP
(n=4) versus mouse ES cells (n=5). Data are plotted as the mean±SEM. *** Pb0.001 by
Fig. 6. The role of P2X7 receptors inmouse ES cell colony number and self-renewal. Mouse ES cells were plated at approximately 166 cells/cm2 and cultured for 5 days (in the presence or
absence of 10 μM A438079) prior to counting the percentage of colonies intensely staining for pure alkaline phosphatase activity (A–B) and total colony number normalised to control
untreated cells (C). Cells cultured in GMEMor KO-DMEM (indicated in the ﬁgure) for 5 days as described inMaterials andmethods prior to analysis for colony number (C) and frequency
of pure alkaline phosphatase positive colonies (B) where data are plotted as the mean±SEM (n=3). (A) A representative image of mES cells cultured in KO-DMEM in the presence or
absence of 10 μMA438079. Scale bar=400 μm. (D)Nanog-GFP expression inmES cells cultured inKO-DMEM for 48 and 72 h in the absence or presence of 10 μMA438079 as indicated in
the ﬁgure. GFP ﬂuorescence analysed by ﬂow cytometry, representative images in ﬁgure with GFP-ve control cells in insert. (E) Mean GFP ﬂuorescence from ﬂow cytometry experiments
plotted as a histogram with n values indicated in the ﬁgure. Data plotted as mean±SEM.
776 B.A.N. Thompson et al. / Cellular Signalling 24 (2012) 770–778receptors. We have demonstrated the expression of P2X7 mRNA
encoding several receptor isoforms in undifferentiated mouse ES
cells and present data that support a key role of this receptor in ES
cell survival. Several studies have investigated the expression of ion
channels in ES cells and demonstrated the expression of GABA(A) re-
ceptors, voltage-gated calcium channels and potassium channels
[36,37]. In mouse ES cells GABA signalling is reported to havedifferential actions on proliferation and differentiation according the
receptor subtype activated. The discovery of ES cell expressed P2X7
receptors adds to the repertoire of ion channels that play an impor-
tant role in controlling embryonic stem cell behaviour.
We have demonstrated that mouse ES cell P2X7 receptors couple
to the opening of an ion channel followed by downstream membrane
permeabilisation leading to the inﬂux of Et+. A recent study has
777B.A.N. Thompson et al. / Cellular Signalling 24 (2012) 770–778identiﬁed multiple splice variants of rat and mouse P2X7 receptors,
where two splice variants differing in exon 1 have been studied in detail
for rat and found to have distinct functional properties [38]. By RT-PCR,
we have detected the expression of P2X7(k) mRNA. Homomeric rat
P2X7(k) was found to have increased sensitivity to ATP, with currents
activated at 10 μMATP in contrast to 100 μM–1 mMATP required to ac-
tivate P2X7(a). In addition, the off-kinetics were strikingly different be-
tween P2X7(a) and P2X7(k)where a short agonist application evoked a
current that reversed upon agonist removal for P2X7(a) whilst P2X7(k)
currents were sustained upon agonist removal. Assuming comparable
pharmacological properties for mouse P2X7(k) receptors then our bio-
physical data would suggest that homomeric P2X7(k) does not contrib-
ute to ES cell P2X7-mediated currents but this does not exclude a
heteromeric receptor assembly that incorporates P2X7(k). Further
studies are required to elucidate the variant(s) contribution to mouse
ES cell P2X7 receptor-dependent responses.
In the adult organism, P2X7 is expressed in cells of the hematopoi-
etic lineage, epithelium and endothelium [9]. The functional role of
P2X7 receptors has been extensively characterised in immune cells
where activation is associated with inﬂammatory responses and P2X7
acts as a cytotoxic receptor associated with apoptotic or necrotic cell
death [24,39]. Indeed, chronic activation of ES cell P2X7 receptors by ex-
ogenous millimolar levels of ATP leads to detectable necrotic cell death
within 1 h. However, there is also increasing evidence in the literature
to support a role for P2X7 as a pro-survival receptor. Much of this data
comes from studies using recombinant P2X7 receptors expressed in a
HEK293 cell line, which leads to increased cell survival in serum-free
conditions [16,17]. It is proposed that low levels of ATP in the extracel-
lular milieu lead to the basal activation of P2X7 receptors that couple to
signalling pathways to promote cell survival [16–18]. Increased expres-
sion of P2X7 is proposed to contribute to the altered growth patterns
and consequently the pathology of several cancers including chronic
lymphocytic leukemia [15,19]. In mouse ES cells, we found that a selec-
tive P2X7 antagonist reduced their plating efﬁciency, resulting in for-
mation of fewer colonies, suggesting that functional P2X7 receptors
are required for optimal in vitro survival of mouse ES cells. This would
ﬁt with the current model that P2X7 can function both as a pro-
survival or cytotoxic receptor dependent on the mode of receptor acti-
vation. The current model for P2X7 leading to altered cell survival
and/or proliferation is primarily based on altered intracellular Ca2+ sig-
nalling. P2X7 receptor expression is reported to lead to an increase in
mitochondrial and endoplasmic reticulumCa2+ content, changes in cel-
lular ATP levels and activation of nuclear factor of activated T cells com-
plex 1 (NFATc1), that protects from apoptotic cell death from other
stimuli [16–18].Wehypothesise that P2X7-dependent changes in intra-
cellular Ca2+ are an important regulator of mouse ES cell colony surviv-
al. Cytosolic Ca2+ signalling has been shown to play an important role in
embryonic development [40]. Indeed, one study has demonstrated cell
cycle-dependent Ca2+ oscillations are required for G1/S progression of
mouse embryonic stem cells [41]. However, the role for P2X7 in optimal
mouse ES cell survival in vitro would suggest that P2X7 knockout mice
might show embryonic lethality. The fact that three different P2X7
knockout mice have now been successfully generated might suggest
that the in vivo role of P2X7 is not as important in survival as seen in
vitro or the incomplete block of stem cell survival is not sufﬁcient to
alter embryo survival [42–44]. To further understand the potential
role of P2X7 and ATP signalling in development, it would be fundamen-
tal to measure intra-blastocyst ATP levels and pericellular ATP levels at
the inner cell mass. These are technically challenging experiments,
however, technologies are developing to measure extracellular peri-
cellular ATP in vivo and this would be an interesting direction of future
research.
Finally, in differentiated cells of the immune system, P2X7 recep-
tor activation is classically associated with necrotic or apoptotic cell
death. Extracellular ATP is described as a ‘danger-associated molecu-
lar pattern’ linked with inﬂammatory signalling and cell death. In thecurrent study, we provide evidence for coupling of P2X7 receptor
stimulation to cell necrosis. These data, coupled with the expression
of P2X7 receptors in mouse ES cells, suggest that receptor activity
may be involved in basal cell survival in the inner cell mass as well
as providing a mechanism to detect gross stress leading to excessive
ATP secretion within the blastocyst. It would therefore be important
to understand the expression proﬁle of P2X7 receptors during differ-
entiation to an array of progenitor cells that may be used for cell re-
placement therapies, as transplantation of ES cell-derived cells
expressing P2X7 may have adverse consequences to cell survival in
material to be used for cellular therapy and in transplanted tissues.
Indeed, P2X7 expression has been demonstrated in mouse neural
progenitor cells where receptor activation is associated with necrotic
cell death [45].
5. Conclusions
Together these data demonstrate a previously unreported role for
P2X7 receptors in control of ES cell biology, where these receptors
can mediate a pro-survival or pro-death signal depending on the
mode of activation.
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